Hereditary Transthyretin Amyloidosis: Eplontersen improves Quality of Life

被引:0
|
作者
Simon, Annika
机构
关键词
D O I
10.1055/a-2304-1328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:330 / 330
页数:1
相关论文
共 50 条
  • [31] Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
    Mónica Inês
    Teresa Coelho
    Isabel Conceição
    Lara Ferreira
    Mamede de Carvalho
    João Costa
    Orphanet Journal of Rare Diseases, 15
  • [32] A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis
    Acaster, Sarah
    Lo, Siu Hing
    Nestler-Parr, Sandra
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [33] CHARACTERISTICS OF PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS-POLYNEUROPATHY (ATTRV PN) IN NEURO-TTRANSFORM, A PHASE 3 STUDY OF EPLONTERSEN
    Cruz, Marcia Waddington
    Barroso, Fabio
    Berk, John
    Chao, Chi-Chao
    Dasgupta, Noel
    Dyck, P. James B.
    Gertz, Morie
    Obici, Laura
    Parman, Yesim
    Weiler, Markus
    Wixner, Jonas
    Viney, Nicholas
    Jung, Shiangtung
    Schneider, Eugene
    Coelho, Teresa
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S144 - S144
  • [34] Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
    Ines, Monica
    Coelho, Teresa
    Conceicao, Isabel
    Ferreira, Lara
    de Carvalho, Mamede
    Costa, Joao
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [35] Transthyretin amyloidosis: a little history of hereditary amyloidosis
    Benson, Merrill D.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 76 - 77
  • [36] Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis
    Suhr, OB
    Svendsen, IH
    Ohlsson, PI
    Lendoire, J
    Trigo, P
    Tashima, K
    Ranlov, PJ
    Ando, Y
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (03): : 187 - 191
  • [37] SIMULATED TREATMENT COMPARISON AND MATCHINGADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF EPLONTERSEN AND VUTRISIRAN FOR THE TREATMENT OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Karam, C.
    Gillmore, J. D.
    Chen, G.
    Jenkins, N. C.
    Hale, M. J.
    Chen, J.
    Viney, N. J.
    Schneider, E.
    VALUE IN HEALTH, 2023, 26 (12) : S46 - S47
  • [38] The impact of disease and treatment on quality of life as assessed by the Norfolk Quality of Life Questionnaire in hereditary transthyretin amyloidosis relative to diabetic neuropathy
    Yarlas, A.
    Lovley, A.
    Guthrie, S. D.
    Pollock, M.
    Kessler, A. Sikora
    Coelho, T.
    Obici, L.
    Conceicao, I.
    McCausland, K. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 713 - 713
  • [39] A MULTI-METHOD APPROACH TO AN INDIRECT TREATMENT COMPARISON OF EPLONTERSEN AND VUTRISIRAN FOR THE TREATMENT OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Karam, C.
    Gillmore, J. D.
    Chen, G.
    Jenkins, N. C.
    Hale, M. J.
    Taylor, G. M.
    Chen, J.
    Viney, N. J.
    Schneider, E.
    VALUE IN HEALTH, 2023, 26 (06) : S279 - S279
  • [40] Inotersen improves quality of life and neuropathy in patients with hereditary transthyretin (hATTR) amyloidosis with polyneuropathy: results of the phase 3 study NEURO-TTR
    Coelho, T.
    Wang, A.
    Waddington Cruz, M.
    Polydefkis, M.
    Dyck, P.
    Scheinberg, M.
    Plante-Bordeneuve, V.
    Berk, J.
    Barroso, F.
    Adams, D.
    Brannagan, T.
    Whelan, C.
    Merlini, G.
    Drachman, B.
    Heitner, S.
    Conceicao, I.
    Schmidt, H.
    Vita, G.
    Gamez, J.
    Gane, E.
    Gorevic, P.
    Souza Bulle Oliveira, A.
    Monia, B.
    Gertz, M.
    Benson, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 376 - 376